TABLE 1.
Compound group and compound | HIV-1 (RF) replication
|
HIV-1 RT activity
|
||
---|---|---|---|---|
IC50 (μM)b | r2 | IC50 (μM)b | r2 | |
NNRTIs | ||||
Efavirenz | 0.0007 ± 0.0004 | 0.966 | 0.041 ± 0.012 | 0.981 |
DPC082 | 0.0004 ± 0.0001 | 0.966 | 0.054 ± 0.020 | 0.993 |
DPC083 | 0.0003 ± 0.0001 | 0.950 | 0.041 ± 0.0009 | 0.976 |
DPC961 | 0.0004 ± 0.0003 | 0.926 | 0.024 ± 0.004 | 0.973 |
DPC963 | 0.0004 ± 0.0002 | 0.967 | 0.019 ± 0.003 | 0.979 |
NVP | 0.018 ± 0.003 | 0.938 | 2.34 ± 0.21 | 0.985 |
NRTIs | ||||
AZT | 0.022 ± 0.014 | 0.973 | 0.0029 ± 0.0004 | 0.990 |
3TC | 0.153 ± 0.023 | 0.987 | 1.45 ± 0.53 | 0.991 |
PI, NFV | 0.005 ± 0.001 | 0.959 | NDc | ND |
All values are derived from a minimum of 10 independent experiments for each compound in each assay.
Values are means ± standard deviations.
ND, not determined.